Sulfachlorpyridazine

Sulfachlorpyridazine

SCHEMBL94138

Nc1ccc(S(=O)(=O)Nc2ccc(Cl)nn2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 1.00
KDM4E B2RXH2 2/20 1.00
NPSR1 Q6W5P4 2/20 1.00
GAA P10253 1/20 0.71
SMN1; SMN2 Q16637 3/20 0.64
CYP2C19 P33261 2/20 0.64
MAPT P10636 4/20 0.52
ALDH1A1 P00352 3/20 0.52
PKM P14618 1/20 0.52
HPGD P15428 1/20 0.52
HTT P42858 1/20 0.52
ADRA1A P35348 1/20 0.50
EPHX2 P34913 1/20 0.49
HTR6 P50406 2/20 0.49
PDE4A P27815 1/20 0.49
AGO2 Q9UKV8 1/20 0.49
PRMT1 Q99873 1/20 0.49
AURKA O14965 1/20 0.49
DHFR P00374 1/20 0.49
TSHR P16473 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfachlorpyridazine SCHEMBL29468586 1.00 LMNA (1.00) LMNAKDM4ENPSR1GAASMN1; SMN2
Sulfachlorpyridazine SCHEMBL38650642 1.00 LMNA (1.00) LMNAKDM4ENPSR1GAASMN1; SMN2
Sulfachlorpyridazine SCHEMBL203598 0.98 LMNA (0.97) LMNAKDM4ENPSR1GAASMN1; SMN2
Sulfachlorpyridazine SCHEMBL28539972 0.98 LMNA (0.97) LMNAKDM4ENPSR1GAASMN1; SMN2
Sulfachlorpyridazine SCHEMBL23420334 0.89 LMNA (0.80) LMNAKDM4ENPSR1GAASMN1; SMN2
Sulfabromomethazine SCHEMBL6815308 0.84 LMNA (0.70) LMNAKDM4ENPSR1GAASMN1; SMN2
SCHEMBL1055106 0.84 KDM4E (0.72) LMNAKDM4ENPSR1GAASMN1; SMN2
SCHEMBL924615 0.83 GAA (1.00) LMNAKDM4ENPSR1GAASMN1; SMN2
SCHEMBL11263565 0.82 LMNA (0.69) LMNAKDM4ENPSR1GAASMN1; SMN2
Sulfamethoxypyridazine SCHEMBL10777132 0.78 LMNA (1.00) LMNAKDM4ENPSR1SMN1; SMN2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2296 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-121021404-B Synthesis process of high-purity sulfachloropyridazine sodium 寿光富康制药有限公司 2026-05-12 CN claimed
CN-120195301-A Method and system for detecting various antibiotics in water based on artificial intelligence 广东中加检测技术股份有限公司 2025-06-24 CN claimed
CN-118465149-B Pretreatment method for improving analysis efficiency of various antibiotics in organic fertilizer 生态环境部南京环境科学研究所 2025-06-13 CN claimed
CN-116890109-B Preparation method of flexible Raman detection substrate and application of flexible Raman detection substrate in rapid detection of drug residues in water 广东省科学院测试分析研究所(中国广州分析测试中心) 2025-06-03 CN claimed
US-20250160275-A1 COMPOUNDS FOR MODIFYING MEIOTIC RECOMBINATION AND METHODS RELATING THERETO THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 2025-05-22 US claimed
CN-119936254-A Method for simultaneously screening 56 drug residues in animal-derived hot pot food materials based on high-resolution mass spectrometry technology 重庆市食品药品检验检测研究院 2025-05-06 CN claimed
CN-119915935-A Synchronous detection method for 42 antibiotics in river mouth multi-environment medium 华东师范大学 2025-05-02 CN claimed
CN-119907692-A Isolated targeted delivery system for the treatment of gliomas 塞尔丽思股份公司 2025-04-29 CN claimed
CN-119846127-A Method for rapidly detecting various antibiotics in environmental water body by on-line solid phase extraction-liquid chromatography-triple quadrupole mass spectrometry 昆明理工大学 2025-04-18 CN claimed
EP-4536217-A1 CO-AGENTS AS THERAPY AGAINST ANAEROBIC PATHOGENS Fleurir Abx LLC (US) 2025-04-16 EP claimed
WO-1995020387-A1 METHOD FOR PREVENTING OR REDUCING PHOTOSENSITIVITY AND/OR PHOTOTOXICITY REACTIONS TO MEDICATIONS G.D. SEARLE & CO. (US) 1995-08-03 WO claimed
EP-0572560-A4 USE OF PHARMACEUTICAL COMPOUNDS IN THE TREATMENT OF SYMPTOMS OF DISORDERS RELATED TO NEUROLOGICAL DISEASES AND ETIOLOGICALLY RELATED SYMPTOMOLOGY. SHAPIRO HOWARD K (US) 1995-04-26 EP claimed
EP-0572560-A1 USE OF PHARMACEUTICAL COMPOUNDS IN THE TREATMENT OF SYMPTOMS OF DISORDERS RELATED TO NEUROLOGICAL DISEASES AND ETIOLOGICALLY RELATED SYMPTOMOLOGY SHAPIRO, Howard, K. (US) 1993-12-08 EP claimed
WO-1992014456-A1 USE OF PHARMACEUTICAL COMPOUNDS IN THE TREATMENT OF SYMPTOMS OF DISORDERS RELATED TO NEUROLOGICAL DISEASES AND ETIOLOGICALLY RELATED SYMPTOMOLOGY SHAPIRO HOWARD K (US) 1992-09-03 WO claimed
US-4599416-A Process for the preparation of aqueous solutions of potentiated sulfonamides HOFFMANN-LA ROCHE INC. (US) 1986-07-08 US claimed
US-4532245-A Pharmaceutical compositions HOFFMANN-LA ROCHE INC. (US) 1985-07-30 US claimed
US-4470978-A TRIMETHOPRIM, PHENOXYETHANOL, SULFACHLOROPYRIDAZINE ABIC LTD. (IL) 1984-09-11 US claimed
US-4423043-A VETERINARY MEDICINE CIBA-GEIGY CORPORATION (US) 1983-12-27 US claimed
US-4315931-A MICROBIOCIDES, INFECTIOUS DISEASES BASF AKTIENGESELLSCHAFT (DE) 1982-02-16 US claimed
US-4094976-A ANTICOCCIDIAL CYCLICAMINO ETHANOLS AND ESTERS THEREOF MERCK & CO., INC. (US) 1978-06-13 US claimed